HST
35
2
ILMN
38
7
MSFT
46
3
UNP
36
3
ISRG
64
3
FOXA
67
3
MDLZ
26
2
SCHW
45
2
PGR
49
4
SYF
78
7
PH
53
3
KEY
33
3
NOC
47
2
F
39
3
BAC
42
3
NVDA
56
5
TROW
43
8
FITB
30
2
XEL
50
-3
AMP
43
3
HST
35
2
ILMN
38
7
MSFT
46
3
UNP
36
3
ISRG
64
3
FOXA
67
3
MDLZ
26
2
SCHW
45
2
PGR
49
4
SYF
78
7
PH
53
3
KEY
33
3
NOC
47
2
F
39
3
BAC
42
3
NVDA
56
5
TROW
43
8
FITB
30
2
XEL
50
-3
AMP
43
3
Financhill
Back

OP Bancorp Vs. NovoCure Industry Stock Comparison

Sell
50

OPBK
OP Bancorp

Last Price:
$15.43
Seasonality Move:
-0.55%
Sell
49

NVCR
NovoCure

Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
50
OP Bancorp (OPBK) is a Sell

Is OP Bancorp a Buy, Sell or Hold?

  • The current OP Bancorp [OPBK] share price is $15.58. The Score for OPBK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • OPBK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPBK Stock Price Chart

What is OP Bancorp's stock price today?

  • The OP Bancorp share price today is $15.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPBK is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.19
    The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

OPBK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 40.15 Sell
Chaikin Money Flow: 10384 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.77 - 17.61) Sell
Bollinger Bands (100): (12.34 - 16.38) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.94 Buy
Relative Strength Index (14 RSI): 58.79 Buy
Chaikin Money Flow: -60501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.36 - 32.64) Buy
Bollinger Bands (100): (14.38 - 25.86) Buy

OPBK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.62 Sell
20-day SMA: 16.44 Sell
50-day SMA: 16.19 Sell
200-day SMA: 12.22 Buy
8-day EMA: 15.71 Sell
20-day EMA: 16.12 Sell
50-day EMA: 15.79 Sell
200-day EMA: 13.12 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.52 Sell
20-day SMA: 30.41 Sell
50-day SMA: 23.25 Buy
200-day SMA: 18.89 Buy
8-day EMA: 30.36 Sell
20-day EMA: 29.22 Buy
50-day EMA: 25.18 Buy
200-day EMA: 21.21 Buy

OP Bancorp Earnings Growth & OPBK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.35 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

OP Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):